These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

541 related articles for article (PubMed ID: 32948575)

  • 21. Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.
    Xiong LY; Ouk M; Wu CY; Rabin JS; Lanctôt KL; Herrmann N; Black SE; Edwards JD; Swardfager W
    Alzheimers Res Ther; 2021 Sep; 13(1):147. PubMed ID: 34479635
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Estimating Alzheimer's Disease Progression Rates from Normal Cognition Through Mild Cognitive Impairment and Stages of Dementia.
    Davis M; O Connell T; Johnson S; Cline S; Merikle E; Martenyi F; Simpson K
    Curr Alzheimer Res; 2018; 15(8):777-788. PubMed ID: 29357799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the feasibility of a randomised controlled trial examining the effect of hearing aids on cognitive decline in elderly individuals: a study protocol.
    Fuchten D; Smit AL; Huenges Wajer IMC; Rhebergen KS; Stegeman I
    BMJ Open; 2023 Dec; 13(12):e074176. PubMed ID: 38151274
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vestibular Function in Older Adults With Cognitive Impairment: A Systematic Review.
    Bosmans J; Jorissen C; Gilles A; Mertens G; Engelborghs S; Cras P; Van Ombergen A; Van Rompaey V
    Ear Hear; 2021; 42(5):1119-1126. PubMed ID: 33974775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of brain training on brain blood flow (The Cognition and Flow Study-CogFlowS): protocol for a feasibility randomised controlled trial of cognitive training in dementia.
    Beishon L; Evley R; Panerai RB; Subramaniam H; Mukaetova-Ladinska E; Robinson T; Haunton V
    BMJ Open; 2019 May; 9(5):e027817. PubMed ID: 31122994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Self-Reported Hearing Loss and Longitudinal Cognitive Function in a Cohort Enriched with Risk for Alzheimer's Disease.
    Fields TN; Mueller KD; Koscik RL; Johnson SC; Okonkwo OC; Litovsky RY
    J Alzheimers Dis; 2020; 78(3):1109-1117. PubMed ID: 33104032
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distinct disease mechanisms may underlie cognitive decline related to hearing loss in different age groups.
    van 't Hooft JJ; Pelkmans W; Tomassen J; Smits C; Legdeur N; den Braber A; Barkhof F; van Berckel B; Yaqub M; Scheltens P; Pijnenburg YA; Visser PJ; Tijms BM
    J Neurol Neurosurg Psychiatry; 2023 Apr; 94(4):314-320. PubMed ID: 36639225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Olfactory function and neuropsychological profile to differentiate dementia with Lewy bodies from Alzheimer's disease in patients with mild cognitive impairment: A 5-year follow-up study.
    Yoon JH; Kim M; Moon SY; Yong SW; Hong JM
    J Neurol Sci; 2015 Aug; 355(1-2):174-9. PubMed ID: 26076880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective Evaluation of Cognitive Health and Related Factors in Elderly at Risk for Developing Alzheimer's Dementia: A Longitudinal Cohort Study.
    Udeh-Momoh C; Price G; Ropacki MT; Ketter N; Andrews T; Arrighi HM; Brashear HR; Robb C; Bassil DT; Cohn M; Curry LK; Su B; Perera D; Giannakopoulou P; Car J; Ward HA; Perneczky R; Novak G; Middleton L
    J Prev Alzheimers Dis; 2019; 6(4):256-266. PubMed ID: 31686098
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Utility of an Alzheimer's Disease Risk-Weighted Polygenic Risk Score for Predicting Rates of Cognitive Decline in Preclinical Alzheimer's Disease: A Prospective Longitudinal Study.
    Porter T; Burnham SC; Milicic L; Savage G; Maruff P; Lim YY; Li QX; Ames D; Masters CL; Rainey-Smith S; Rowe CC; Salvado O; Groth D; Verdile G; Villemagne VL; Laws SM;
    J Alzheimers Dis; 2018; 66(3):1193-1211. PubMed ID: 30412495
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MGEKN; Tabet N
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD002854. PubMed ID: 28418065
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sino Longitudinal Study on Cognitive Decline (SILCODE): protocol for a Chinese longitudinal observational study to develop risk prediction models of conversion to mild cognitive impairment in individuals with subjective cognitive decline.
    Li X; Wang X; Su L; Hu X; Han Y
    BMJ Open; 2019 Jul; 9(7):e028188. PubMed ID: 31350244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MyCOACH (COnnected Advice for Cognitive Health): a digitally delivered multidomain intervention for cognitive decline and risk of dementia in adults with mild cognitive impairment or subjective cognitive decline-study protocol for a randomised controlled trial.
    Amos JG; Zheng L; Eramudugolla R; Parekh D; Huque MH; Delbaere K; Lautenschlager N; Anstey KJ
    BMJ Open; 2023 Oct; 13(10):e075015. PubMed ID: 37903606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CERAD neuropsychological compound scores are accurate in detecting prodromal alzheimer's disease: a prospective AddNeuroMed study.
    Paajanen T; Hänninen T; Tunnard C; Hallikainen M; Mecocci P; Sobow T; Tsolaki M; Vellas B; Lovestone S; Soininen H
    J Alzheimers Dis; 2014; 39(3):679-90. PubMed ID: 24246420
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of effects between SMR/delta-ratio and beta1/theta-ratio neurofeedback training for older adults with Mild Cognitive Impairment: a protocol for a randomized controlled trial.
    Marlats F; Djabelkhir-Jemmi L; Azabou E; Boubaya M; Pouwels S; Rigaud AS
    Trials; 2019 Jan; 20(1):88. PubMed ID: 30696475
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-Term Cognitive Prognosis of Profoundly Deaf Older Adults After Hearing Rehabilitation Using Cochlear Implants.
    Mosnier I; Vanier A; Bonnard D; Lina-Granade G; Truy E; Bordure P; Godey B; Marx M; Lescanne E; Venail F; Poncet C; Sterkers O; Belmin J
    J Am Geriatr Soc; 2018 Aug; 66(8):1553-1561. PubMed ID: 30091185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vitamin E for Alzheimer's dementia and mild cognitive impairment.
    Farina N; Llewellyn D; Isaac MG; Tabet N
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD002854. PubMed ID: 28128435
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic and Prognostic Value of the Combination of Two Measures of Verbal Memory in Mild Cognitive Impairment due to Alzheimer's Disease.
    Sala I; Illán-Gala I; Alcolea D; Sánchez-Saudinós MB; Salgado SA; Morenas-Rodríguez E; Subirana A; Videla L; Clarimón J; Carmona-Iragui M; Ribosa-Nogué R; Blesa R; Fortea J; Lleó A
    J Alzheimers Dis; 2017; 58(3):909-918. PubMed ID: 28527215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Prevalence of Vestibular Loss in Mild Cognitive Impairment and Alzheimer's Disease.
    Wei EX; Oh ES; Harun A; Ehrenburg M; Xue QL; Simonsick E; Agrawal Y
    Curr Alzheimer Res; 2019; 16(12):1143-1150. PubMed ID: 31418661
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mild cognitive impairment in Parkinson's disease versus Alzheimer's disease.
    Besser LM; Litvan I; Monsell SE; Mock C; Weintraub S; Zhou XH; Kukull W
    Parkinsonism Relat Disord; 2016 Jun; 27():54-60. PubMed ID: 27089852
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.